Spectral AI, Inc.

NASDAQ:MDAI

Medical - Devices

Healthcare
$1.57 +0.28%

+$0.01 today

Market cap
$50.53M
Beta
1.15
P/E (TTM)
-4.0
EPS (TTM)
-$0.45
52W Low $1.18High $3.21

Volume 0.07M

Average 1.00M

MDAI Pre-Tax Margin

Income before tax as a percentage of revenue.

Spectral AI, Inc.NASDAQ: MDAI

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -85.7%

Pre-tax margin was -85.7% in Q1 FY2026, down 130.0 pp from a year earlier. On a trailing-twelve-month basis it was -86.0%, down 56.3 pp year over year. Over 3 fiscal years it narrowed by 27.4 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-85.7%-101.4 pp QoQ
Last fiscal yearDec 2025
-38.5%+12.4 pp YoY
LTMMar 2026
-86.0%-56.3 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-130.0 pp——
1 year+12.4 pp——
3 years-27.4 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-38.5%
Year-over-year change
+12.4pp

Pre-Tax Margin vs competitors

How MDAI compares with its peers on the latest reported figures

  • MDAI's LTM Mar 2026 pre-tax margin of -86.0% is the 5th highest of the 7 companies compared; the peer median is -50.9%.
  • Its year-over-year change of -56.3 pp is the 5th highest of 7, against a peer median of +2.2 pp.
  • Over three fiscal years its change of -27.4 pp compares with a peer median of +58.9 pp.
MDAI Competitors Peer median
Pre-Tax Margin for MDAI and competitors
Company Period LTM level YoY 3-year change
IPSCCentury Therapeutics, Inc.FY2025-8.8% +1884.9 pp+2507.8 pp
ECORelectroCore, Inc.LTM Mar 2026-44.9% +1.5 pp+219.4 pp
SRTSSensus Healthcare, Inc.LTM Mar 2026-50.6% -59.3 pp-97.9 pp
TELATELA Bio, Inc.LTM Jun 2026-51.2% +3.0 pp+58.9 pp
MDAISpectral AI, Inc.LTM Mar 2026-86.0% -56.3 pp-27.4 pp
KPTIKaryopharm Therapeutics Inc.LTM Mar 2026-129.0% -85.0 pp-29.2 pp
COEPCoeptis Therapeutics, Inc.LTM Mar 2026-910.7% +17056.9 pp—
EQEquillium, Inc.FY2025— ——
TELOTelomir Pharmaceuticals, Inc. Common StockFY2025— ——
Peer median (excluding MDAI) -50.9%+2.2 pp+58.9 pp

Competitors are the stored peer set for MDAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue15.24M25.37M18.06M29.58M19.65M
Cost of Revenue8.19M14.53M10.18M16.31M10.73M
Gross Profit7.05M10.84M7.88M13.27M8.93M
Gross Margin46.3%42.7%43.6%44.9%45.4%
Research & Development00029.58M19.65M
Selling, General & Admin11.23M13.48M20.86M19.86M17.53M
Operating Expenses11.23M13.48M20.86M19.86M17.53M
Depreciation & Amortization1K568K722K588K635K
EBITDA(4.09M)(2.24M)(20.12M)(11.49M)(5.42M)
EBITDA Margin-26.8%-8.8%-111.4%-38.8%-27.6%
Operating Income(4.18M)(2.65M)(12.98M)(6.58M)(8.6M)
Operating Margin-27.4%-10.4%-71.9%-22.3%-43.8%
Interest Income021K172K14K(886K)
Interest Expense0002.97M1.51M
Other Income / Expenses93K(159K)(7.86M)(8.46M)1.04M
Income Before Tax(4.09M)(2.81M)(20.84M)(15.04M)(7.56M)
Pre-Tax Margin-26.8%-11.1%-115.4%-50.9%-38.5%
Income Tax Expense(98K)106K11K271K11K
Net Income(3.99M)(2.91M)(20.85M)(15.32M)(7.57M)
Net Margin-26.2%-11.5%-115.5%-51.8%-38.5%
EPS (Basic)(0.33)(0.16)(1.48)(0.85)(0.29)
EPS (Diluted)(0.33)(0.16)(1.48)(0.85)(0.29)
Weighted Avg Shares17.88M17.88M14.09M17.93M26.52M
Weighted Avg Shares (Diluted)17.88M17.88M14.09M17.93M26.52M

Spectral AI, Inc.

NASDAQ:MDAI

Intrinsic Alpha fair value

Locked

Current Price

$1.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.